文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

慢性阻塞性肺疾病中的咽喉反流——一项多中心研究。

Laryngopharyngeal reflux in chronic obstructive pulmonary disease - a multi-centre study.

机构信息

Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland.

Department of Pneumology, Kantonsspital St. Gallen, Rorschacherstrasse 95, St. Gallen, CH-9001, Switzerland.

出版信息

Respir Res. 2020 Aug 21;21(1):220. doi: 10.1186/s12931-020-01473-2.


DOI:10.1186/s12931-020-01473-2
PMID:32825819
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7441701/
Abstract

Reflux of gastric content has been associated with recurrent exacerbations of chronic obstructive pulmonary disease (COPD). We aimed to assess the prevalence of laryngopharyngeal reflux (LPR) in COPD and if LPR is a contributing factor to clinically relevant outcomes in COPD. We evaluated a total of 193 COPD patients (GOLD I-IV) with a 24-h laryngo-pharyngeal pΗ-monitor. LPR was observed in 65.8% of COPD patients and it was not significantly associated with clinically relevant outcomes of COPD. Treatment with PPI significantly decreased the upright RYAN score (p = 0.047) without improving lung function. Furthermore, the presence or severity of LPR cannot be diagnosed based solely on symptoms and questionnaires.

摘要

胃内容物反流与慢性阻塞性肺疾病(COPD)的反复发作有关。我们旨在评估 LPR(喉咽反流)在 COPD 中的患病率,以及 LPR 是否是 COPD 中临床相关结局的一个促成因素。我们评估了总共 193 名 COPD 患者(GOLD I-IV)的 24 小时喉咽 pH 监测。在 65.8%的 COPD 患者中观察到 LPR,但它与 COPD 的临床相关结局无显著相关性。PPI 治疗显著降低了直立 RYAN 评分(p=0.047),而对肺功能没有改善。此外,不能仅根据症状和问卷来诊断 LPR 的存在或严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6793/7441701/16252fea2884/12931_2020_1473_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6793/7441701/9b9bca06a473/12931_2020_1473_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6793/7441701/16252fea2884/12931_2020_1473_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6793/7441701/9b9bca06a473/12931_2020_1473_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6793/7441701/16252fea2884/12931_2020_1473_Fig2_HTML.jpg

相似文献

[1]
Laryngopharyngeal reflux in chronic obstructive pulmonary disease - a multi-centre study.

Respir Res. 2020-8-21

[2]
Proton pump inhibitor treatment improves pulmonary function in acute exacerbations of COPD patients with 24-hour Dx-pH monitoring-diagnosed laryngopharyngeal reflux.

Clin Respir J. 2021-5

[3]
Clinical significance of laryngopharyngeal reflux in patients with chronic obstructive pulmonary disease.

Int J Chron Obstruct Pulmon Dis. 2015-7-15

[4]
Incidence and treatment results of laryngopharyngeal reflux in chronic obstructive pulmonary disease.

Eur Arch Otorhinolaryngol. 2009-8

[5]
Nissen fundoplication proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale.

World J Gastroenterol. 2017-5-21

[6]
Laryngopharyngeal Reflux Disease is More Severe in Obese Patients: A Prospective Multicenter Study.

Laryngoscope. 2021-11

[7]
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?

World J Gastroenterol. 2012-8-28

[8]
Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.

Respirology. 2016-3-11

[9]
Acidic Pharyngeal Reflux Does Not Correlate with Symptoms and Laryngeal Injury Attributed to Laryngopharyngeal Reflux.

Dig Dis Sci. 2018-11-14

[10]
Characteristics of laryngopharyngeal reflux in patients with chronic otitis media.

Am J Otolaryngol. 2018

引用本文的文献

[1]
Laryngopharyngeal reflux disease: Updated examination of mechanisms, pathophysiology, treatment, and association with gastroesophageal reflux disease.

World J Gastroenterol. 2024-4-28

[2]
Common gastrointestinal diseases and chronic obstructive pulmonary disease risk: a bidirectional Mendelian randomization analysis.

Front Genet. 2023-11-16

[3]
Elucidating the Link: Chronic Obstructive Pulmonary Disease and the Complex Interplay of Gastroesophageal Reflux Disease and Reflux-Related Complications.

Medicina (Kaunas). 2023-7-8

[4]
Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa.

Sci Rep. 2021-10-5

本文引用的文献

[1]
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.

Eur Respir J. 2020-1

[2]
Time-course of upper respiratory tract viral infection and COPD exacerbation.

Eur Respir J. 2019-10-10

[3]
Utility of 24-hour pharyngeal pH monitoring and clinical feature in laryngopharyngeal reflux disease.

Acta Otolaryngol. 2019-3

[4]
Intensified Therapy with Inhaled Corticosteroids and Long-Acting β-Agonists at the Onset of Upper Respiratory Tract Infection to Prevent Chronic Obstructive Pulmonary Disease Exacerbations. A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial.

Am J Respir Crit Care Med. 2018-5-1

[5]
Review article: gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease.

Aliment Pharmacol Ther. 2017-11-29

[6]
Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?

Respir Med. 2016-6

[7]
Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.

Respirology. 2016-3-11

[8]
Laryngopharyngeal symptoms in patients with chronic obstructive pulmonary disease.

Eur Arch Otorhinolaryngol. 2016-4

[9]
Clinical significance of laryngopharyngeal reflux in patients with chronic obstructive pulmonary disease.

Int J Chron Obstruct Pulmon Dis. 2015-7-15

[10]
Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease.

Respir Med. 2015-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索